Navigation Links
Researchers identify new way the malaria parasite and red blood cells interact
Date:3/10/2009

RICHMOND, Va. (March 10, 2009) -- Virginia Commonwealth University Life Sciences researchers have discovered a new mechanism the malaria parasite uses to enter human red blood cells, which could lead to the development of a vaccine cocktail to fight the mosquito-borne disease.

Malaria is transmitted to humans through bites from mosquitoes. According to the Centers for Disease Control and Prevention, between 350 million and 500 million cases of malaria occur world-wide annually, and more than 1 million people, mostly children living in areas of Africa south of the Sahara, die each year from it.

For decades, researchers have known that a molecule called glycophorin B, which is found on the surface of human red blood cells, is important for invasion of the malaria parasite. However, the specific molecule by which the malaria parasite attaches itself to invade the host was not known until now.

The team examined how the malaria parasite, Plasmodium falciparum, interacts with red blood cells using a biochemical test that looks specifically at how the parasite and host bind to each other. The findings revealed that the EBL-1 molecule is the specific attachment site used by the parasite on glycophorin B.

The study was published online in the Early Edition of the Proceedings of the National Academy of Sciences the week of March 9.

"We have now identified how the parasite binds to glycophorin B on the red blood cells. Down the road, the EBL-1 molecule could be used as a vaccine target against malaria as part of a multivalent vaccine, or vaccine cocktail," said principal investigator Ghislaine Mayer, Ph.D., assistant professor in the VCU Department of Biology.

Additionally, Mayer and her team hypothesize that the malaria parasite may be the cause of the loss of the gene for glycophorin B in the pygmies of Ituri forest in the Democratic Republic of Congo.

According to Mayer, these findings suggest that
'/>"/>

Contact: Sathya Achia Abraham
sbachia@vcu.edu
804-827-0890
Virginia Commonwealth University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Iowa State researchers developing clean, renewable energy for ethanol industry
2. Researchers discover gene mutations that cause childhood brain cancer
3. Pitt researchers describe molecular 2-step leading to protein clumps of Huntingtons disease
4. Climate change affecting Europes birds now, say researchers
5. CSHL researchers pinpoint structure-building role for 2 non-coding RNAs
6. Ben-Gurion University of the Negev researchers develop new reversible, green window technology
7. Two UT Southwestern researchers awarded Sloan fellowships
8. 2 McGill researchers garner prestigious NSERC Steacie Fellowships
9. Texas Obesity Research Center at UH assembles researchers to discuss obesity
10. U-M researchers ID gene involved in pancreatic cancer
11. USC researchers identify gene variant associated with both autism and gastrointestinal dysfunction

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ent at the University of Southampton,s School of O...nography Centre, Southampton (NOCS) has formally d...he deep sea. , Hall discovered the new species i...um of Natural History in Washington. Explaining th...include some of the largest crustaceans currently ...
(Date:12/1/2009)...s National Primate Research Center, Emory Universi...ic prairie voles, an important step toward unlocki...e application of this technology will enable scien...hat will help identify the brain mechanisms of soc...is advancement may also have important implication...
(Date:12/1/2009)...r,s disease, nerve cell degeneration plays a cruci...y possibly be derived from steering the generation...een published in the current issue of the renowned...ears ago, neurogenesis the process of nerve cell ...e adult brain. The textbooks asserted that dead ne...
Breaking Biology News(10 mins):King crab family bigger than ever 2Yerkes researchers create first transgenic prairie voles 2New source discovered for the generation of nerve cells in the brain 2Revolutionizing the diagnosis of serious disease 47651 1Revolutionizing the diagnosis of serious disease 47651 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 1Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 3Make Sure Your Baby is Seeing the Most Important Things in His World 47647 1Make Sure Your Baby is Seeing the Most Important Things in His World 47647 2Make Sure Your Baby is Seeing the Most Important Things in His World 47647 3Make Sure Your Baby is Seeing the Most Important Things in His World 47647 4Make Sure Your Baby is Seeing the Most Important Things in His World 47647 5
... easy to use, and rapid alternative to blood-based... testing according to a new MUHC study. The study...est is 100 per cent accurate and patients?preferre..., a postdoctoral fellow at the McGill University H... individuals for HIV infection at the Mahatma Gand...
...rom the University of Sheffield have received join...e Research Council (EPSRC) and the Ministry of Def...ct bacteria. The new method will use a polymer whi...rs bacteria, allowing scientists to easily identif...onal methodologies. , The new technology will be...
...l climate change causes changes in the species com...ow coastal oceans. This applies also to fish popul...een global warming and declining fish stocks were ...der to estimate future changes, it is essential to...ater temperature on the biology of organisms under...
Other Biology News:Rapid oral HIV test shows great promise according to MUHC-led research 2How fish species suffer as a result of warmer waters 2
(Date:12/2/2009)..., , LIBREVILLE, Gabon, December 2 /PRNe...n Africa: Everyone,s Problem and Heritage" , ...iversity, 2-3 June 2010 the,Gabonese Republic is h...Gabon) on the issue of safeguarding biological res...by government and state leaders, ministers,scient...
(Date:12/2/2009)..., , CAMBRIDGE, Mass., Dec. 2 /PRNewswi...er the leaders in technology development and produ... MEMS, announced the December 11th deadline for te..., Now in its 14th year, TechConnect World, in ass...itute (NSTI), and the Clean Technology and Sustain...
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 ...n its novel oral JAK2 inhibitor, SB1518, at The Am...nd Exposition in New Orleans. ,, Data will be p...dose-escalation trial of SB1518 detailing its safe...ic (PK/PD) profile in dose levels ranging from 100...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewswir... or the "Company") (NYSE: SCR ), a leading pharm... manufacturing, and marketing of branded,generic a...ounced that 105 of,its drugs have been included in..., which was issued by China,s Ministry of Human Re...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
... a biotech company, raising money is a saga that n...ve to do two things: execute on the timely achieve... investors and look at the structuring of your nex...from. Most angel investors aren,t repetitive inves...st VCs usually commit for two or more rounds but m...
neuronfarm
...to-based Millennium Research Group predicts the ...es, Europe and Japan will grow by 15 percent annua...ufacturers profiled in Millennium,s study, entitle...ons 2005," include Pfizer, Shire Pharmaceuticals a...market that generated more than $1.3 billion last ...
Other Biology Technology:Financing of biotech companies so far in 2005: A Midwest odyssey 2Financing of biotech companies so far in 2005: A Midwest odyssey 3Financing of biotech companies so far in 2005: A Midwest odyssey 4Financing of biotech companies so far in 2005: A Midwest odyssey 5Alzheimer's drug market to hit $5.5 billion by 2009, study says 2
3' RACE Adapter Primer from Invitrogen
...ic peptide derived from the N-terminal region of t...teins. Specificity: Specific for the human occlud... Caco-2 cell lysates). Reactivity with rat mouse ...tern blotting Immunohistochemistry Immunofluoresce...
ARCA (Anti Reverse Cap Analog) from Ambion
TRIzol LS Reagent from Invitrogen
Biology Products: